Back

A Forward Genetic Screen in Caenorhabditis elegans for Genes that Modulate α-synuclein-Induced Neurodegeneration through the Mitochondrial UPR

Willicott, K.; Iroegbu, J. D.; Greene, M. R.; Meyers, A. C.; Davidson-Tullis, R.; Martin, R.; Berkowitz, L. A.; Caldwell, G. A.; Caldwell, K. A.

2026-06-15 genetics
10.64898/2026.06.11.731199 bioRxiv
Show abstract

Overexpression of -synuclein (-syn), an inherently disordered protein, triggers chronic activation of the mitochondrial unfolded protein response (UPRmt) pathway in Caenorhabditis elegans with enhanced dopaminergic (DAergic) neurodegeneration. Introduction of a loss-of-function(lf) mutation in atfs-1, the main transcriptional regulator of the UPRmt, into -syn nematodes results in significant neuroprotection from -syn-induced DA neuron loss, indicating that compensatory mechanisms provide neuroprotection. We performed a F3 forward genetic screen in C. elegans atfs-1(lf) mutants to identify molecular components associated with the modulation of neurodegeneration via UPRmt signaling in -syn-expressing DA neurons. Homozygous mutant animals were examined for enhanced neurodegeneration; multiple independent alleles were uncovered. Among these, we identified new nonsense alleles encoding the histone lysine demethylases (H3K27me3), jmjd-1.2 and jmjd-3.1. Another line carried a nonsense allele of twk-14. This gene encodes a conserved protein termed KCNK12 in mammals that facilitates passive background K+ leak currents to set and stabilize resting membrane potential. To further examine the association of these gene products in DA neurodegeneration, mutants and/or RNA interference were employed. DA neurodegeneration was observed in the -syn + atfs-1(lf) background when jmjd-1.2, jmjd-3.1, or twk-14 were individually depleted. These results provide evidence that jmjd-1.2 and jmjd-3.1, which encode previously characterized H3K27me3 demethylases, and the uncharacterized twk-14 gene product, orthologous to human KCNK12, naturally confer protection from -syn neurotoxicity.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
G3: Genes|Genomes|Genetics
35 papers in training set
Top 0.1%
18.8%
2
PLOS Genetics
862 papers in training set
Top 0.7%
12.1%
3
GENETICS
483 papers in training set
Top 0.7%
8.0%
4
PLOS ONE
5266 papers in training set
Top 21%
8.0%
5
Scientific Reports
3612 papers in training set
Top 10%
6.9%
50% of probability mass above
6
Disease Models & Mechanisms
20 papers in training set
Top 0.1%
4.9%
7
eLife
5828 papers in training set
Top 29%
4.1%
8
G3: Genes, Genomes, Genetics
252 papers in training set
Top 2%
2.5%
9
Neurobiology of Disease
148 papers in training set
Top 2%
2.2%
10
Proceedings of the National Academy of Sciences
2444 papers in training set
Top 25%
1.9%
11
Human Molecular Genetics
141 papers in training set
Top 2%
1.4%
12
PLOS Biology
486 papers in training set
Top 7%
1.4%
13
Heredity
64 papers in training set
Top 0.8%
1.1%
14
Nature Communications
5641 papers in training set
Top 50%
1.1%
15
Journal of Biomedical Science
17 papers in training set
Top 0.2%
1.1%
16
Communications Biology
993 papers in training set
Top 24%
1.1%
17
Journal of Neurogenetics
11 papers in training set
Top 0.2%
1.1%
18
Cell Death & Disease
21 papers in training set
Top 0.4%
0.9%
19
Frontiers in Genetics
230 papers in training set
Top 5%
0.9%
20
Aging Cell
165 papers in training set
Top 2%
0.9%
21
Frontiers in Cell and Developmental Biology
233 papers in training set
Top 4%
0.9%
22
PLOS Pathogens
820 papers in training set
Top 10%
0.6%
23
BMC Genomics
406 papers in training set
Top 9%
0.6%